Alcohol-Attributable Cancer: Update From the Global Burden of Disease 2021 Study

By sjmartinez • April 28, 2025

Danpanichkul P, Pang Y, Díaz LA, White TM, Sirimangklanurak S, Auttapracha T, Suparan K, Syn N, Jatupornpakdee P, Saowapa S, Ng CH, Kaewdech A, Lui RN, Fallon MB, Yang JD, Louvet A, Noureddin M, Liangpunsakul S, Jepsen P, Lazarus JV, Arab JP, Wijarnpreecha K. Alcohol-Attributable Cancer: Update From the Global Burden of Disease 2021 Study. Aliment Pharmacol Ther. 2025 Apr 27. doi: 10.1111/apt.70163. Epub ahead of print. PMID: 40287931.

Tags: Alcohol, Alcoholic liver disease, Cancer, Cedars Sinai DoM, Digestive Diseases, Epidemiology, oncology, public health, Publications

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial

McDonald CM, Villa C, Soslow JH, Maharry K, Hogan N, Binks M, Berth KC, Elliott KA, Taylor M, Hor KN, Signorovich J, Henricson EK, Phan[...]

Hidden risk in normal myocardial perfusion scans: AI-detected proximal coronary calcium on CT attenuation maps improves prognosis

Zhou J, Miller RJH, Shanbhag A, Killekar A, Han D, Patel KK, Pieszko K, Yi J, Urs MK, Ramirez G, Lemley M, Kavanagh PB, Liang[...]

Correction to: Consensus and Controversies about Diagnosing GH deficiency – A Delphi Survey by the GH Research Society

Radovick S, Arlien-Søborg MC, Boguszewski MCS, Bidlingmaier M, Johannsson G, Grimberg A, Ho KKY, Biller BMK, Choong CS, Hoffman AR, Backeljauw P, Boguszewski CL, Bollerslev[...]